枫蓼肠胃康颗粒联合兰索拉唑三联疗法治疗慢性胃炎50例临床观察

目的:研究枫蓼肠胃康颗粒联合兰索拉唑、克拉霉素、甲硝唑三联疗法对慢性胃炎的临床疗效。方法:将100例幽门螺杆菌(Hpylori)阳性的慢性胃炎患者随机分为观察组及对照组。观察组给予枫蓼肠胃康颗粒3g/次,3次/日,共4周;兰索拉唑30mg/次,2次/日,共4周;克拉霉素0.5g/次,2次/日,共7天;甲硝唑0.4g/次,2次/日,共7天。对照组除枫蓼肠胃康颗粒外的其余3种药物,用法如观察组。疗程结束后将两组Hpylori根除率及临床症状缓解率相比较。结果:观察组Hpylori根除率及临床症状缓解率均明显高于对照组(P<0.05)。结论:枫蓼肠胃康颗粒联合兰索拉唑、克拉霉素、甲硝唑三联疗法治疗Hpylori相关慢性胃炎能明显提高Hpylori根除率及临床症状缓解率。

Objective：To research the clinical curative effect of Intestines and Fengliao stomach kang particles joint Lansoprazole, Clarithromycin,Metronidazole Hpylori eradication triple plan for chronic gastritis. Methods： 100 cases of chronic gastritis Hpylori positive patients were randomly divided into observation group and control group. Patients in the observation group were gave intestines and Fengliao stomach kang particles （every time 3g,three times a day for four weeks） , Lansoprazole （every time 30rag, twice a day for four weeks ） , Clarithromycin （ every time 0.5g,twice a day,for seven days）, Metronidazole （ every time 0. 4g, twice a day, for seven days ）. Patients in the control group were treated with the same drags except intestines and Fengliao stomach kang particles. After the treatment, Hpylori eradicate rate and Clinical symptoms ease rate of the two groups were compared. Results：The ob- servation group Hpylori eradicate rate and clinical symptoms rates were significantly higher than the control group （ P 〈 0. 05 ）. Conclusion：The treatment of Intestines and Fengliao stomach kang particles joint Lansoprazole, Clarithromycin, Metronidazole H. pylori eradication triple plan for Hpylori related chronic gastritis can obviously increase Hpylori eradicate rate and clinical symptoms ease rate, and is worth to clinical promot.